Characteristics of Reported Deaths Among Fully Vaccinated Persons With Coronavirus Disease 2019-United States, January-April 2021

被引:8
|
作者
Watkins, Louise K. Francois [1 ]
Mitruka, Kiren [1 ]
Dorough, Layne [1 ,2 ]
Bressler, Sara S. [1 ]
Kugeler, Kiersten J. [1 ]
Sadigh, Katrin S. [1 ,3 ]
Birhane, Meseret G. [1 ]
Nolen, Leisha D. [1 ]
Fischer, Marc [1 ]
机构
[1] Ctr Dis Control & Prevent, COVID 19 Emergency Response, Atlanta, GA USA
[2] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA
[3] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA
关键词
Breakthrough; COVID-19; death; postvaccination; SARS-CoV-2; Vaccine; SARS-COV-2; INFECTIONS; UNITED-STATES; COVID-19; HOSPITALIZATIONS; CARE; MULTICENTER; IMPACT; ISRAEL; ADULTS;
D O I
10.1093/cid/ciac066
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Vaccines against coronavirus disease 2019 (COVID-19) are highly efficacious, but severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections do occur after vaccination. We characterized COVID-19 cases among fully vaccinated persons with an outcome of death. Methods We analyzed COVID-19 cases voluntarily reported to the Centers for Disease Control and Prevention by US health departments from 1 January to 30 April 2021. We included cases among US residents with a positive SARS-CoV-2 test result >= 14 days after completion of an authorized primary vaccine series and who had a known outcome (alive or dead) as of 31 May 2021. When available, specimens were sequenced for viral lineage and death certificates were reviewed for cause(s) of death. Results Of 8084 fully vaccinated persons with reported COVID-19 during the surveillance period, 245 (3.0%) died. Compared with patients who remained alive, those who died were older (median age, 82 vs 57 years;), more likely to reside in a long-term care facility (51% vs 18%), and more likely to have >= 1 underlying health condition associated with risk for severe disease (64% vs 24%) (all P < .01). Among 245 deaths, 191 (78%) were classified as COVID-19 related. Of 106 deaths with available death certificates, COVID-19 was listed for 81 deaths (77%). There were no differences in the type of vaccine administered or the most common viral lineage (B.1.1.7). Conclusions COVID-19 deaths are rare in fully vaccinated persons, occurring most commonly in those with risk factors for severe disease, including older age and underlying health conditions. All eligible persons should be fully vaccinated against COVID-19 and follow other prevention measures to mitigate exposure risk. Deaths among persons fully vaccinated against coronavirus disease 2019 (COVID-19) were rare and occurred most commonly among those with risk factors for severe COVID-19, including older age and underlying health conditions. Most deaths were COVID-19 related.
引用
收藏
页码:E645 / E652
页数:8
相关论文
共 50 条
  • [1] Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020
    Burke, Rachel M.
    Calderwood, Laura
    Killerby, Marie E.
    Ashworth, Candace E.
    Berns, Abby L.
    Brennan, Skyler
    Bressler, Jonathan M.
    Morano, Laurel Harduar
    Lewis, Nathaniel M.
    Markus, Tiffanie M.
    Newton, Suzanne M.
    Read, Jennifer S.
    Rissman, Tamara
    Taylor, Joanne
    Tate, Jacqueline E.
    Midgley, Claire M.
    [J]. EMERGING INFECTIOUS DISEASES, 2021, 27 (09) : 2323 - 2332
  • [2] Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020
    McGovern, Olivia L.
    Stenger, Mark
    Oliver, Sara E.
    Anderson, Tara C.
    Isenhour, Cheryl
    Mauldin, Matthew R.
    Williams, Nia
    Griggs, Eric
    Bogere, Tonny
    Edens, Chris
    Curns, Aaron T.
    Lively, Joana Y.
    Zhou, Yingtao
    Xu, Songli
    Diaz, Maureen H.
    Waller, Jessica L.
    Clarke, Kevin R.
    Evans, Mary E.
    Hesse, Elisabeth M.
    Morris, Sapna Bamrah
    McClung, Robert P.
    Cooley, Laura A.
    Logan, Naeemah
    Boyd, Andrew T.
    Taylor, Allan W.
    Bajema, Kristina L.
    Lindstrom, Stephen
    Elkins, Christopher A.
    Jones, Christopher
    Hall, Aron J.
    Graitcer, Samuel
    Oster, Alexandra M.
    Fry, Alicia M.
    Fischer, Marc
    Conklin, Laura
    Gokhale, Runa H.
    [J]. PLOS ONE, 2021, 16 (04):
  • [3] Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020
    Bajema, Kristina L.
    Oster, Alexandra M.
    McGovern, Olivia L.
    Lindstrom, Stephen
    Stenger, Mark R.
    Anderson, Tara C.
    Isenhour, Cheryl
    Clarke, Kevin R.
    Evans, Mary E.
    Chu, Victoria T.
    Biggs, Holly M.
    Kirking, Hannah L.
    Gerber, Susan, I
    Hall, Aron J.
    Fry, Alicia M.
    Oliver, Sara E.
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (06): : 166 - 169
  • [4] Performance of Oropharyngeal Swab Testing Compared With Nasopharyngeal Swab Testing for Diagnosis of Coronavirus Disease 2019-United States, January 2020-February 2020
    Patel, Monita R.
    Carroll, Darin
    Ussery, Emily
    Whitham, Hilary
    Elkins, Christopher A.
    Noble-Wang, Judith
    Rasheed, James Kamile
    Lu, Xiaoyan
    Lindstrom, Stephen
    Bowen, Virginia
    Waller, Jessica
    Armstrong, Gregory
    Gerber, Susan
    Brooks, John T.
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (03) : 482 - 485
  • [5] An estimate of excess deaths among people with HIV during the coronavirus disease 2019 pandemic in the United States, 2020
    Zhu, Weiming
    Huang, Ya-lin A.
    Song, Ruiguang
    Wiener, Jeffrey
    Neblett-Fanfair, Robyn N.
    Kourtis, Athena P.
    Hoover, Karen W.
    [J]. AIDS, 2023, 37 (05) : 851 - 853
  • [6] A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021-February 2022
    Vititoe, Sarah E.
    Govil, Priya
    Baglivo, Aidan
    Beebe, Elisha
    Garry, Elizabeth M.
    Gatto, Nicolle M.
    Lasky, Tamar
    Chakravarty, Aloka
    Bradley, Marie C.
    Perez-Vilar, Silvia
    Rivera, Donna R.
    Quinto, Kenneth
    Clerman, Andrew
    Rajpal, Anil
    Frajzyngier, Vera
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (07):
  • [7] Increased Deaths From Fungal Infections During the Coronavirus Disease 2019 Pandemic-National Vital Statistics System, United States, January 2020-December 2021
    Gold, Jeremy A. W.
    Ahmad, Farida B.
    Cisewski, Jodi A.
    Rossen, Lauren M.
    Montero, Alejandro J.
    Benedict, Kaitlin
    Jackson, Brendan R.
    Toda, Mitsuru
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E255 - E262
  • [8] Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020
    Bialek, Stephanie
    Gierke, Ryan
    Hughes, Michelle
    McNamara, Lucy A.
    Pilishvili, Tamara
    Skoff, Tami
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (14): : 422 - 426
  • [9] In-Hospital Mortality Among Hospitalized Coronavirus Disease 2019 Patients in the United States: How Did It Change in 2021?
    Moon, Rena C.
    Rosenthal, Ning A.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [10] Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019-United States, February 12-March 28, 2020
    Chow, Nancy
    Fleming-Dutra, Katherine
    Gierke, Ryan
    Hall, Aron
    Hughes, Michelle
    Pilishvili, Tamara
    Ritchey, Matthew
    Roguski, Katherine
    Skoff, Tami
    Ussery, Emily
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (13): : 382 - 386